DrugCite
Search

PROCHLORPERAZINE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Prochlorperazine Adverse Events Reported to the FDA Over Time

How are Prochlorperazine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Prochlorperazine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Prochlorperazine is flagged as the suspect drug causing the adverse event.

Most Common Prochlorperazine Adverse Events Reported to the FDA

What are the most common Prochlorperazine adverse events reported to the FDA?

Nausea
95 (2.46%)
Vomiting
86 (2.22%)
Completed Suicide
75 (1.94%)
Drug Ineffective
58 (1.5%)
Anxiety
52 (1.34%)
Dyspnoea
50 (1.29%)
Dystonia
50 (1.29%)
Tremor
46 (1.19%)
Insomnia
45 (1.16%)
Hypersensitivity
44 (1.14%)
Constipation
43 (1.11%)
Show More Show More
Drug Interaction
37 (.96%)
Convulsion
32 (.83%)
Death
31 (.8%)
Depression
31 (.8%)
Drug Hypersensitivity
30 (.78%)
Muscular Weakness
30 (.78%)
Feeling Abnormal
29 (.75%)
Somnolence
29 (.75%)
Asthenia
28 (.72%)
Diarrhoea
28 (.72%)
Pruritus
27 (.7%)
Dizziness
26 (.67%)
Swollen Tongue
26 (.67%)
Agitation
25 (.65%)
Condition Aggravated
25 (.65%)
Blood Cholesterol Increased
24 (.62%)
Gait Disturbance
24 (.62%)
Cerebrovascular Accident
23 (.59%)
Dyskinesia
23 (.59%)
Muscle Spasms
23 (.59%)
Swelling
23 (.59%)
Rash Pruritic
22 (.57%)
Weight Decreased
22 (.57%)
Akathisia
21 (.54%)
Cardio-respiratory Arrest
21 (.54%)
Headache
21 (.54%)
Pustular Psoriasis
21 (.54%)
Rash Pustular
21 (.54%)
Dehydration
20 (.52%)
Fatigue
20 (.52%)
Hypotension
20 (.52%)
Rash Papular
20 (.52%)
Speech Disorder
20 (.52%)
Decreased Appetite
19 (.49%)
Drug Exposure During Pregnancy
19 (.49%)
Stress
19 (.49%)
Suicidal Ideation
19 (.49%)
Confusional State
18 (.47%)
Heart Rate Increased
18 (.47%)
Cardiac Arrest
17 (.44%)
Panic Attack
17 (.44%)
Chest Pain
16 (.41%)
Dysphagia
16 (.41%)
Malaise
16 (.41%)
Pyrexia
16 (.41%)
Blood Glucose Increased
15 (.39%)
Deep Vein Thrombosis
15 (.39%)
Drug Toxicity
15 (.39%)
Hypoaesthesia
15 (.39%)
Infection
15 (.39%)
Mental Impairment
15 (.39%)
Movement Disorder
15 (.39%)
Neuroleptic Malignant Syndrome
15 (.39%)
Respiratory Arrest
15 (.39%)
Restlessness
15 (.39%)
Medication Error
14 (.36%)
Musculoskeletal Stiffness
14 (.36%)
Ulcer
14 (.36%)
Abdominal Distension
13 (.34%)
Eczema
13 (.34%)
Eosinophilia
13 (.34%)
Lethargy
13 (.34%)
Rash
13 (.34%)
Tachycardia
13 (.34%)
Extrapyramidal Disorder
12 (.31%)
Malignant Neoplasm Progression
12 (.31%)
Overdose
12 (.31%)
Poisoning
12 (.31%)
Dermatitis Atopic
11 (.28%)
Hallucination
11 (.28%)
Muscle Rigidity
11 (.28%)
Nervousness
11 (.28%)
Urinary Tract Infection
11 (.28%)
Vision Blurred
11 (.28%)
Abnormal Behaviour
10 (.26%)
Amnesia
10 (.26%)
Anaphylactic Reaction
10 (.26%)
Anger
10 (.26%)
Angioedema
10 (.26%)
Grand Mal Convulsion
10 (.26%)
Hyperhidrosis
10 (.26%)
Hypertension
10 (.26%)
Kidney Infection
10 (.26%)
Palpitations
10 (.26%)
Parkinsonism
10 (.26%)
Psychiatric Symptom
10 (.26%)
Serotonin Syndrome
10 (.26%)
Trismus
10 (.26%)
Abnormal Dreams
9 (.23%)
Anorexia
9 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Prochlorperazine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Prochlorperazine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Prochlorperazine

What are the most common Prochlorperazine adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Prochlorperazine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Prochlorperazine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Prochlorperazine According to Those Reporting Adverse Events

Why are people taking Prochlorperazine, according to those reporting adverse events to the FDA?

Nausea
2410
Drug Use For Unknown Indication
733
Vomiting
566
Product Used For Unknown Indication
426
Prophylaxis
158
Prophylaxis Of Nausea And Vomiting
144
Show More Show More
Antiemetic Supportive Care
71
Premedication
52
Vertigo
41
Migraine
23
Pain
21
Ill-defined Disorder
19
Enteritis Infectious
16
Headache
14
Dizziness
14
Abdominal Discomfort
13
Hyperemesis Gravidarum
11
Drug Withdrawal Syndrome
9
Anxiety
8
Crohns Disease
8
Gastric Disorder
8
Schizophrenia
7
Cancer Pain
7
Foetal Exposure During Pregnancy
7
Metastatic Renal Cell Carcinoma
7
Malaise
6
Gastroenteritis
5
Hiccups
5
Biliary Colic
5
Psychotic Disorder
4
Motion Sickness
3
Gout
3
Pancreatic Injury
3
Diarrhoea
3
Multiple Myeloma
3
Influenza Like Illness
3
Adenosquamous Cell Lung Cancer
2
Gallbladder Disorder
2
Menieres Disease
2
Gastrooesophageal Reflux Disease
2
Abdominal Pain
2
Infusion Related Reaction
2
Large Intestine Carcinoma
2
Depression
2
Gallbladder Pain
2
Disease Complication
2
Drug Exposure During Pregnancy
2
Chronic Lymphocytic Leukaemia
2
Ulcer
2
Gastric Cancer
2
Urinary Tract Infection
2

Drug Labels

LabelLabelerEffective
Prochlorperazine MaleateBryant Ranch Prepack01-MAR-98
Prochlorperazine G & W LABORATORIES, INC.18-DEC-08
ProchlorperazineSTAT RX USA LLC24-SEP-09
Prochlorperazine MaleatePhysicians Total Care, Inc.16-MAR-10
Prochlorperazine EdisylatePhysicians Total Care, Inc.21-APR-10
Prochlorperazine EdisylateBedford Laboratories21-APR-10
ProchlorperazinePhysicians Total Care, Inc.09-AUG-10
Prochlorperazine EdisylateGeneral Injectables & Vaccines, Inc25-AUG-10
Prochlorperazine MaleateMylan Pharmaceuticals Inc.15-SEP-10
Prochlorperazine Maleate PD-Rx Pharmaceuticals, Inc.15-SEP-10
Prochlorperazine MaleatePD-Rx Pharmaceuticals, Inc.15-SEP-10
Prochlorperazine MaleatePD-Rx Pharmaceuticals, Inc.15-SEP-10
Prochlorperazine MaleatePD-Rx Pharmaceuticals, Inc.15-SEP-10
Prochlorperazine MaleateUDL Laboratories, Inc.17-DEC-10
ComproPD-Rx Pharmaceuticals, Inc.22-DEC-10
ComproPaddock Laboratories, Inc.22-DEC-10
Prochlorperazine MaleateRebel Distributors Corp04-JAN-11
Prochlorperazine EdisylateBaxter Healthcare Corporation04-JAN-11
Prochlorperazine Maleate JUBILANT CADISTA PHARMACEUTICALS, INC.01-MAR-11
Prochlorperazine MaleateREMEDYREPACK INC. 11-APR-11
Prochlorperazine MaleateREMEDYREPACK INC. 30-JUN-11
Prochlorperazine MaleateSandoz Inc21-OCT-11
Prochlorperazine MaleateLake Erie Medical & Surgical Supply DBA Quality Care Prodcuts LLC06-DEC-11
Prochlorperazine Maleate Dispensing Solutions, Inc.07-FEB-12
Prochlorperazine MaleatePreferred Pharmaceuticals, Inc05-APR-12
Prochlorperazine MaleateNCS HealthCare of KY, Inc dba Vangard Labs20-APR-12
Prochlorperazine EdisylateCardinal Health29-MAY-12
Prochlorperazine MaleatePreferred Pharmaceuticals, Inc.25-JUL-12
Prochlorperazine MaleateTeva Pharmaceuticals USA Inc06-SEP-12
Prochlorperazine MaleateREMEDYREPACK INC. 12-SEP-12
Prochlorperazine MaleateBryant Ranch Prepack18-JAN-13
Prochlorperazine MaleateLake Erie Medical DBA Quality Care Products LLC14-FEB-13
Prochlorperazine MaleatePreferred Pharmaceuticals, Inc.14-MAR-13
Prochlorperazine MaleateCardinal Health19-MAR-13

Prochlorperazine Case Reports

What Prochlorperazine safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Prochlorperazine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Prochlorperazine.